Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 859
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Birmingham AL, Atlanta GA, Greenville SC, Louisville KY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Location: Birmingham AL, Atlanta GA, Jonesboro AR, Lexington KY,
Sponsor: Arga Medtech SA
Sex: All
Age: 18 - 70+
Code: NCT06784466
Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Birmingham AL, Mobile AL, Atlanta GA, Louisville KY,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Birmingham AL, Flowood MS, Atlanta GA, Columbia SC,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 70
Code: NCT07598708
Phase2, Phase3, Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
for
Ulcerative Colitis, Crohn's Disease
Location: Birmingham AL, Mobile AL, Atlanta GA, Southaven MS,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06581328
Recruiting
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for
Narcolepsy Type 1
Location: Birmingham AL, Atlanta GA, Gainesville GA, Columbia SC,
Sponsor: Takeda
Sex: All
Age: 16 - 70
Code: NCT05816382
Phase2, Phase3, Recruiting
Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy
for
Chemotherapy Induced Nausea and Vomiting
Location: Mount Olive AL
Sponsor: Simon Williamson Clinic
Sex: All
Age: 18+
Code: NCT06065722
Phase2, Recruiting
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Homewood AL, Anniston AL, Mobile AL, Hermitage TN,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase2, Recruiting
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
for
COVID-19, COVID
Location: Birmingham AL, Madison AL, Baton Rouge LA
Sponsor: Aptitude Medical Systems
Sex: All
Age: 2+
Code: NCT06744660
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Columbus MS, New Albany MS, Grenada MS, Oxford MS,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Columbus MS, New Albany MS, Grenada MS, Oxford MS,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Columbus MS, New Albany MS, Grenada MS, Oxford MS,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase2, Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Location: Birmingham AL, Jackson TN, Southaven MS, Atlanta GA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06875973
Phase3, Recruiting
Evaluation of Probiotics and the Development of Clostridium Difficile Associated Diarrhea in Patients Receiving Antibiotics
for
Development of Clostridium Difficile Associated Diarrhea
Location: Birmingham AL
Sponsor: St. Vincent's East, Birmingham, Alabama
Sex: All
Age: 19+
Code: NCT01873872
Recruiting
FELLAShip to Better Health
for
High Blood Glucose, High Cholesterol,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: Male
Age: 18+
Code: NCT07220213
Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants